C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 417/12 (2006.01) A61K 31/427 (2006.01) A61P 3/10 (2006.01)
Patent
CA 2370262
A polymorphic form of 5-[4-[2-(N-methyl-N-(2- pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione, maleic acid salt (the "Polymorph") characterised in that it provides: (i) an infra red spectrum containing peaks at 1752, 1546, 1154, 621, and 602 cm-1; and/or (ii) a Raman spectrum containing peaks at 1751, 1243 and 602 cm-1; and/or (iii) a solid- state nuclear magnetic resonance spectrum containing peaks at 111.9, 114.8, 119.6, 129.2, 134.0, 138.0, 144.7, 153.2, 157.1, 170.7, 172.0 and 175.0 ppm; and/or (iv) an X-ray powder diffraction (XRPD) pattern which gives calculated lattice spacings of 6.46, 5.39, 4.83, 4.68, 3.71, 3.63, 3.58, and 3.48 Angstroms; a process for preparing such a compound, a pharmaceutical composition containing such a compound and the use of such a compound in medicine.
Forme polymorphe de 5-[4-[2-(N-méthyle-N-(2-pyridyl)amino)éthoxy]benzyl]thiazolidine-2,4-dione, sel d'acide maléique (le <= polymorphe >=) caractérisée par le fait qu'elle produit : (i) un spectre infrarouge contenant des crêtes à 1752, 1546, 1154, 621 et 602 cm?-1¿; et/ou (ii) un spectre de Raman contenant des crêtes à 1751, 1243 et 602 cm?-1¿; et/ou (iii) un spectre de résonance magnétique nucléaire par semi-conducteur contenant des crêtes à 111,9, 114,8, 119,6, 129,2, 134, 138, 144,7, 153,2, 157,1, 170,7, 172 et 175 ppm ; et/ou (iv) une configuration de diffraction de poudre aux rayons X (XRPD) produisant des espacements de réseau calculés de 6,46, 5,39, 4,83, 4,68, 3,71, 3,63, 3,58 et 3,48 Angströms ; procédé servant à préparer ce composé, composition pharmaceutique contenant ce composé et son utilisation médicale.
Blackler Paul David James
Giles Robert Gordon
Moore Stephen
Sasse Michael John
Gowling Lafleur Henderson Llp
Smithkline Beecham Plc
LandOfFree
Thiazolidinedione derivative and its use as antidiabetic does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thiazolidinedione derivative and its use as antidiabetic, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thiazolidinedione derivative and its use as antidiabetic will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1361535